Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ PFE NVS SNY AUD Bitcoins Junk Bonds Furniture Cars 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Processing. Please wait...

Novartis Number of Shares Shorted

 
 Companies |  Insiders  | Dashboard  
     
Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.

Novartis

Shares Shorted

=

Shorted by Public

+

by Institutions

=
2.66 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.
Compare Novartis to competition

Novartis Number of Shares Shorted Assessment

Based on recorded statements Novartis AG has 2.66 M of outstending shares currently sold short by investors. This is 21.21% lower than that of Healthcare sector, and 64.8% lower than that of Drug Manufacturers - Major industry, The Number of Shares Shorted for all stocks is 21.08% lower than the firm.

Filter other Stocks by Number of Shares Shorted

Select Number of Shares Shorted Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Novartis is rated below average in number of shares shorted category among related companies.
Follow Novartis Number of Shares Shorted with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Novartis to your reader
 
    
NVS United States NYSE
Novartis AG
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    

Other Novartis Fundamentals

Return On Equity14.99 %
Return On Asset6.52 %
Profit Margin16.71 %
Operating Margin21.70 %
Current Valuation197.63 B
Shares Outstanding2.46 B
Number of Shares Shorted2.66 M
Price to Earning18.87 times
Price to Book2.71 times
Price to Sales3.14 times
Revenue57.8 B
Gross Profit38.8 B
EBITDA17.15 B
Net Income9.66 B
Cash and Equivalents6.04 B
Cash per Share2.46 times
Total Debt20.94 B
Debt to Equity0.31 times
Current Ratio1.02 times
Book Value Per Share27.28 times
Cash Flow from Operations13.51 B
Short Ratio1.40 times
One Year High75.73
One Year Low51.35
Earnings Per Share3.94 times
Price to Earnings To Growth2.73 times
Number of Employees129 K
Beta0.55
Market Capitalization182.72 B
Total Asset124.22 B
Working Capital3.95 B
Current Asset28 B
Current Liabilities24.05 B
Z Score4.8
Probability Of Bankruptcy12.16 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium